Pharmacy and Distribution Services
- Direct-to-site delivery
- Direct-to-patient delivery
- Patient-specific shipments
- Bulk shipments
- Pharmacy and distribution licensure in all states where it's required
Addressing the complexities of clinical trial logistics.
In today's rapidly advancing healthcare industry, groundbreaking new therapies are transforming difficult-to-treat illnesses into manageable, and in some cases, treatable conditions. Clinical trials play a crucial role in these advancements, but they also demand a diverse array of resources to succeed. Clinical Research Services (CRS) and Clinical Trial Solutions (CTS) are McKesson’s integrated clinical trial support capabilities that help sponsors simplify trial logistics, accelerate study execution and deliver investigational therapies to the right patient at the right time. While the quest for groundbreaking medical discoveries continues, we're committed to accelerating patient access to promising new treatments across all therapeutic areas.
McKesson’s Clinical Research Services and Clinical Trial Solutions supports sponsor-led clinical trials through pharmacy distribution, inventory management, logistics and clinical management services.
By simplifying clinical trial logistics for study sponsors, we help expedite the process of getting the right therapy to the right patient at the right time, providing swift access to cutting-edge treatments and fostering hope for a healthier future.
99.99%
McKesson's quality control and reporting systems maintain 99.99% shipping accuracy for clinical trial shipments.
20k+
McKesson has supported phase I - IV clinical trials that have helped over 20,000 patients.
344+
We have 344+ facilities in our U.S. distribution network, which helps us to fulfill most orders within 24 hours of receipt.
Through our joint venture, Sarah Cannon Research Institute (SCRI), we help providers connect their patients to opportunities to participate in clinical trials close to home — supported by the reach of The US Oncology Network.
Sarah Cannon Research Institute (SCRI) partners with biopharma companies to advance the science of cancer treatments.
The US Oncology Network streamlines logistical and administrative access to complex therapies, supporting timely, high‑quality care for patients.
We improve patient outcomes through oncology research and clinical trial access.
Learn more about how McKesson is advancing oncology and multispecialty care.
We are supporting the advancement and commercialization of oncology and specialty therapies through clinical trial access.
Learn more about McKesson’s biopharma capabilities that are advancing healthcare forward.